Independent fund research. Built on SEC filings.

How we research funds

Mutual fund · Large Blend · Vanguard

Vanguard PRIMECAP Fund Investor Shares (VPMCX)

Ticker VPMCX · · Holdings as of Jun 30, 2026

Expense ratio
0.35%$35/yr per $10k
5-yr return
+14.3%annualized
1-yr return
+29.9%as of Dec 2025
Net assets
$96.1Ball share classes
Holdings
173

Bottom line

Is VPMCX a good fund? The bottom line

VPMCX is the Investor share class of Vanguard PRIMECAP Fund, a managed large blend mutual fund from Vanguard.

It charges 0.35% — about $35 a year on every $10,000 invested, cheaper than 86% of large blend funds we track.

It returned +29.9% over one year, +14.3% a year over five years, +15.2% a year over ten (as of Dec 31, 2025, per its prospectus).

With $96.1 billion in net assets and 173 holdings, its largest position is Micron Technology Inc (13.5%) and the top 10 make up 44.9% of the portfolio.

What stands out

  • Low cost: cheaper than 86% of large blend peers
  • 5-year return beat 86% of category peers
  • No front-end sales load
  • Large and established ($96.1 billion)

Updated Nov 19, 2026

What VPMCX invests in

Vanguard PRIMECAP Fund (the Fund) seeks to provide long-term capital appreciation.

The Fund employs an active management approach, investing in stocks considered to have above-average earnings growth potential that is not reflected in their current market prices. The Funds portfolio consists predominantly of large- and mid-capitalization stocks. The Fund may invest up to 25% of its assets in foreign securities, which may include depositary receipts. Foreign securities may be traded on U.S. or foreign markets.

From the fund's prospectus (filed Jan 28, 2026).

VPMCX performance

Fund calendar-year total returns, 2018–2025 2018: −2.0%; 2019: +27.8%; 2020: +17.3%; 2021: +21.8%; 2022: −15.2%; 2023: +28.1%; 2024: +13.5%; 2025: +29.9% −2% 2018 +28% 2019 +17% 2020 +22% 2021 −15% 2022 +28% 2023 +13% 2024 +30% 2025
Fund gain (+) Fund loss (−)
Average annual total returns
1 yr5 yr10 yr
VPMCX+29.9%+14.3%+15.2%
Large Blend median+13.8%+9.7%+10.9%

Source: Fund prospectus, as of Dec 31, 2025

Full VPMCX performance history →

What VPMCX costs

On a $10,000 investment, VPMCX's 0.35% expense ratio costs about $35 a year. The prospectus estimates $443 in total costs over 10 years (assuming 5% annual returns). The median large blend fund charges 0.83%.

See the full VPMCX fee table →

VPMCX top 10 holdings

#Holding% of fund
1Micron Technology Inc13.50%
2Intel Corp6.80%
3Eli Lilly & Co6.76%
4KLA Corp3.85%
5Alphabet Inc3.52%
6AstraZeneca PLC2.35%
7NVIDIA Corp2.33%
8Amazon.com Inc2.05%
9Tesla Inc1.89%
10Biogen Inc1.88%

Source: SEC Form N-PORT, period ended Jun 30, 2026

The top 10 make up 44.9% of the fund. See all top 25 holdings and asset mix →

Alternatives to VPMCX

More funds like VPMCX →

VPMCX FAQ

What is the expense ratio of VPMCX?
VPMCX's expense ratio is 0.35%, which works out to about $35 a year for every $10,000 invested. The prospectus estimates total costs of $443 over 10 years on a $10,000 investment (assuming 5% annual returns).
Is VPMCX a good investment?
It depends on your goals, but the data points to: low cost: cheaper than 86% of large blend peers; 5-year return beat 86% of category peers; no front-end sales load; large and established ($96.1 billion). This is general information, not personalized advice.
What does VPMCX hold?
VPMCX's largest holdings are Micron Technology Inc (13.5%), Intel Corp (6.8%), Eli Lilly & Co (6.8%), KLA Corp (3.8%), Alphabet Inc (3.5%). It holds 173 positions in total as of Jun 30, 2026 (SEC Form N-PORT).
What is VPMCX's 5-year return?
VPMCX returned +14.3% a year over the five years ending Dec 31, 2025, and +15.2% a year over ten years. Past performance does not guarantee future results.
Does VPMCX have a sales load?
No. VPMCX has no front-end sales charge.
Who manages VPMCX?
VPMCX is offered by Vanguard through Vanguard Chester Funds.